Abstract:ABSTRACT Streptomyces coelicolor CR1 ( Sc CR1) has been shown to be a promising biocatalyst for the synthesis of an atorvastatin precursor, ethyl-( S )-4-chloro-3-hydroxybutyrate [( S )-CHBE]. However, limitations of Sc CR1 observed for practical application include low activity and poor stability. In this work, protein engineering was employed to improve the catalytic efficiency and stability of Sc CR1. First, the crystal structure of Sc CR1 complexed with NADH and cosubstrate 2-propanol was solved, and the specific activity of Sc CR1 was increased from 38.8 U/mg to 168 U/mg ( Sc CR1 I158V/P168S ) by structure-guided engineering. Second, directed evolution was performed to improve the stability using Sc CR1 I158V/P168S as a template, affording a triple mutant, Sc CR1 A60T/I158V/P168S , whose thermostability ( T 50 15 , defined as the temperature at which 50% of initial enzyme activity is lost following a heat treatment for 15 min) and substrate tolerance ( C 50 15 , defined as the concentration at which 50% of initial enzyme activity is lost following incubation for 15 min) were 6.2°C and 4.7-fold higher than those of the wild-type enzyme. Interestingly, the specific activity of the triple mutant was further increased to 260 U/mg. Protein modeling and docking analysis shed light on the origin of the improved activity and stability. In the asymmetric reduction of ethyl-4-chloro-3-oxobutyrate (COBE) on a 300-ml scale, 100 g/liter COBE could be completely converted by only 2 g/liter of lyophilized Sc CR1 A60T/I158V/P168S within 9 h, affording an excellent enantiomeric excess ( ee ) of >99% and a space-time yield of 255 g liter −1 day −1 . These results suggest high efficiency of the protein engineering strategy and good potential of the resulting variant for efficient synthesis of the atorvastatin precursor. IMPORTANCE Application of the carbonyl reductase Sc CR1 in asymmetrically synthesizing ( S )-CHBE, a key precursor for the blockbuster drug Lipitor, from COBE has been hindered by its low catalytic activity and poor thermostability and substrate tolerance. In this work, protein engineering was employed to improve the catalytic efficiency and stability of Sc CR1. The catalytic efficiency, thermostability, and substrate tolerance of Sc CR1 were significantly improved by structure-guided engineering and directed evolution. The engineered Sc CR1 may serve as a promising biocatalyst for the biosynthesis of ( S )-CHBE, and the protein engineering strategy adopted in this work would serve as a useful approach for future engineering of other reductases toward potential application in organic synthesis.

Improved O-Chlorobenzoylformate Bioreduction by Stabilizing Aldo-Keto Reductase YtbE with Additives

Improving the Stereoselectivity of Asymmetric Reduction of 3-Oxo Ester to 3-Hydroxy Ester with Pretreatments on Bakers'Yeast

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Engineering the Activity of Old Yellow Enzyme NemR-PS for Efficient Reduction of (<i>E</i>/<i>Z</i>)-Citral to (<i>S</i>)-Citronellol

Bioreduction of Methyl O-Chlorobenzoylformate at 500gl−1 Without External Cofactors for Efficient Production of Enantiopure Clopidogrel Intermediate

Semi-rational Design of Carbonyl Reductase Cat for Synthesis of (R)-Lipoic Acid Precursor

Stereospecific Reduction of Methyl o‐Chlorobenzoylformate at 300 g⋅L−1 without Additional Cofactor using a Carbonyl Reductase Mined from Candida glabrata

Significantly Improved Thermostability of a Reductase CgKR1 from Candida Glabrata with a Key Mutation at Asp 138 for Enhancing Bioreduction of Aromatic Α-Keto Esters

Rational Design of Dehydrogenase/Reductases Based on Comparative Structural Analysis of Prereaction-State and Free-State Simulations for Efficient Asymmetric Reduction of Bulky Aryl Ketones

Computer‐directed rational design enhanced the thermostability of carbonyl reductase LsCR for the synthesis of ticagrelor precursor

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

Protein engineering of carbonyl reductase for asymmetric synthesis of ticagrelor precursor (1S)-2-chloro-1-(3,4-difluorophenyl)ethanol

Characterization of an Allylic/Benzyl Alcohol Dehydrogenase from Yokenella Sp. Strain WZY002, an Organism Potentially Useful for the Synthesis of Α,β-Unsaturated Alcohols from Allylic Aldehydes and Ketones

Redesign of a Short-Chain Dehydrogenase/reductase for Asymmetric Synthesis of Ethyl (R)-2-hydroxy-4-phenylbutanoate Based on Per-Residue Free Energy Decomposition and Sequence Conservatism Analysis

Biocatalytic Properties of a Recombinant Aldo-Keto Reductase with Broad Substrate Spectrum and Excellent Stereoselectivity

Improving the catalytic performance of carbonyl reductase based on the functional loops engineering

Development of an Engineered Ketoreductase with Simultaneously Improved Thermostability and Activity for Making a Bulky Atorvastatin Precursor

Immobilization of Acetobacter Sp. CCTCC M209061 for Efficient Asymmetric Reduction of Ketones and Biocatalyst Recycling

Engineering Streptomyces Coelicolor Carbonyl Reductase for Efficient Atorvastatin Precursor Synthesis

Semirational engineering of an aldo–keto reductase Km AKR for overcoming trade‐offs between catalytic activity and thermostability

Tailoring an aldo-keto reductase KmAKR for robust thermostability and catalytic efficiency by stepwise evolution and structure-guided consensus engineering